Theriva Biologics(TOVX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TOVX Theriva Biologics

盘后交易 02-10 18:09:00 EST

0.1940

+0.0040

+2.11%

盘后0.1945

+0.0005+0.26%

17:55 EST

最高0.1944	最低0.1831	成交量86.02万
今开0.1910	昨收0.1900	日振幅5.95%
总市值692.35万	流通市值677.82万	总股本3,569万
成交额16.25万	换手率2.46%	流通股本3,494万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TOVX","market":"US","secType":"STK","nameCN":"Theriva Biologics","latestPrice":0.194,"timestamp":1770757200000,"preClose":0.19,"halted":0,"volume":860215,"hourTrading":{"tag":"盘后","latestPrice":0.1945,"preClose":0.194,"latestTime":"17:55 EST","volume":29855,"amount":5779.2162568,"timestamp":1770764116923,"change":0.0005,"changeRate":0.002577,"amplitude":0.045361},"delay":0,"changeRate":0.021052631578947385,"floatShares":34939100,"shares":35688300,"eps":-5.5306,"marketStatus":"盘后交易","change":0.004,"latestTime":"02-10 18:09:00 EST","open":0.191,"high":0.1944,"low":0.1831,"amount":162487.98124234998,"amplitude":0.059474,"askPrice":0.2115,"askSize":100,"bidPrice":0.1851,"bidSize":6000,"shortable":0,"etf":0,"ttmEps":-5.5306,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770771600000},"marketStatusCode":4,"adr":0,"exchange":"AMEX","adjPreClose":0.19,"preHourTrading":{"tag":"盘前","latestPrice":0.1906,"preClose":0.19,"latestTime":"09:26 EST","volume":40113,"amount":7731.70934886,"timestamp":1770733612232,"change":0.0006,"changeRate":0.003158,"amplitude":0.044737},"postHourTrading":{"tag":"盘后","latestPrice":0.1945,"preClose":0.194,"latestTime":"17:55 EST","volume":29855,"amount":5779.2162568,"timestamp":1770764116923,"change":0.0005,"changeRate":0.002577,"amplitude":0.045361},"volumeRatio":0.352366},"requestUrl":"/m/hq/s/TOVX","defaultTab":"news","newsList":[{"id":"1167515399","title":"Theriva™ Biologics 将公布VCN-01视网膜母细胞瘤一期临床试验数据于2026年亚太眼科学会","url":"https://stock-news.laohu8.com/highlight/detail?id=1167515399","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167515399?lang=zh_cn&edition=full","pubTime":"2026-02-03 21:02","pubTimestamp":1770123771,"startTime":"0","endTime":"0","summary":"Theriva™ Biologics (TOVX) 宣布，其针对视网膜母细胞瘤的VCN-01一期临床试验数据，将于2026年亚太眼科学会(Apao)上进行展示。这一重要进展标志着公司在肿瘤治疗领域的深入研究取得新突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2605410082","title":"Theriva Biologics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605410082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605410082?lang=zh_cn&edition=full","pubTime":"2026-01-22 23:50","pubTimestamp":1769097054,"startTime":"0","endTime":"0","summary":"北京时间2026年01月22日23时50分，Theriva Biologics, Inc.股票出现波动，股价急速拉升5.00%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新型溶瘤腺病毒平台，以解决高度未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122235054a44a904e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122235054a44a904e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2601286587","title":"Theriva Biologics, Inc.股价重挫11.09% 市值跌11.68万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601286587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601286587?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:50","pubTimestamp":1767624654,"startTime":"0","endTime":"0","summary":"北京时间2026年01月05日22时50分，Theriva Biologics, Inc.股票出现波动，股价快速跳水11.09%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为0.88%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Gh Research Plc、Altimmune, Inc.涨幅较大，Can Fite Biopharma Ltd、Psyence Biomedical Ltd.、Outlook Therapeutics, Inc.较为活跃，换手率分别为1272.20%、19.61%、17.63%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Jasper Therapeutics Inc C/Wts 24/09/2026 、Newcelx Ltd.，振幅分别为62.64%、27.42%、27.37%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新型溶瘤腺病毒平台，以解决高度未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105225054a6f66fa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105225054a6f66fa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"1145679596","title":"Theriva™ Biologics获欧洲药品管理局（EMA）关于VCN-01治疗转移性胰腺导管腺癌（PDAC）三期临床试验设计的积极科学建议","url":"https://stock-news.laohu8.com/highlight/detail?id=1145679596","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145679596?lang=zh_cn&edition=full","pubTime":"2025-12-29 21:02","pubTimestamp":1767013333,"startTime":"0","endTime":"0","summary":"Theriva™ Biologics公司宣布，已获得欧洲药品管理局（EMA）就其候选药物VCN-01用于治疗转移性胰腺导管腺癌（PDAC）的三期临床试验设计所提出的积极科学建议。这一进展标志着VCN-01在临床开发道路上迈出了关键一步，为后续试验的顺利开展奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2586647648","title":"Theriva Biologics, Inc.盘中异动 早盘大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586647648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586647648?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:42","pubTimestamp":1763995373,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日22时42分，Theriva Biologics, Inc.股票出现异动，股价快速上涨5.00%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Enlivex Therapeutics Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Enlivex Therapeutics Ltd.、Pasithea Therapeutics Corp.、Osr Holdings, Inc.较为活跃，换手率分别为471.83%、355.20%、46.80%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Enlivex Therapeutics Ltd.、Bioatla, Inc.，振幅分别为38.86%、31.22%、16.60%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新型溶瘤腺病毒平台，以解决高度未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124224253a4b75815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124224253a4b75815&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2581019450","title":"Theriva Biologics, Inc.盘中异动 股价大跌5.03%报0.281美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581019450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581019450?lang=zh_cn&edition=full","pubTime":"2025-11-06 23:44","pubTimestamp":1762443896,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日23时44分，Theriva Biologics, Inc.股票出现波动，股价大幅下跌5.03%。截至发稿，该股报0.281美元/股，成交量120.206万股，换手率3.56%，振幅3.85%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新型溶瘤腺病毒平台，以解决高度未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106234456a6e65587&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106234456a6e65587&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2577783877","title":"Theriva Biologics, Inc.盘中异动 早盘快速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577783877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577783877?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:31","pubTimestamp":1761053485,"startTime":"0","endTime":"0","summary":"北京时间2025年10月21日21时31分，Theriva Biologics, Inc.股票出现波动，股价急速跳水5.11%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Minerva Neurosciences, Inc、Ibio, Inc.、Plus Therapeutics, Inc.涨幅较大，Minerva Neurosciences, Inc、Ibio, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为664.42%、57.73%、20.74%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Minerva Neurosciences, Inc、Genprex, Inc.，振幅分别为24.64%、19.47%、9.79%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新型溶瘤腺病毒平台，以解决高度未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102121312594d5ebfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102121312594d5ebfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2572665432","title":"Theriva Biologics, Inc.盘中异动 急速上涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572665432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572665432?lang=zh_cn&edition=full","pubTime":"2025-10-04 01:57","pubTimestamp":1759514239,"startTime":"0","endTime":"0","summary":"北京时间2025年10月04日01时57分，Theriva Biologics, Inc.股票出现异动，股价急速拉升5.62%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新型溶瘤腺病毒平台，以解决高度未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251004015720971eaafa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251004015720971eaafa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2560912781","title":"Theriva Biologics, Inc.盘中异动 股价大跌7.19%报0.430美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560912781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560912781?lang=zh_cn&edition=full","pubTime":"2025-08-18 21:31","pubTimestamp":1755523912,"startTime":"0","endTime":"0","summary":"北京时间2025年08月18日21时31分，Theriva Biologics, Inc.股票出现异动，股价大幅下挫7.19%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Propanc Biopharma, Inc.、Aspire Biopharma Holdings, Inc.、Adaptimmune Therapeutics Plc涨幅较大，Soligenix, Inc.、Aspire Biopharma Holdings, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为943.60%、184.88%、126.18%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Propanc Biopharma, Inc.、Aspire Biopharma Holdings, Inc.，振幅分别为22.42%、21.60%、20.06%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新型溶瘤腺病毒平台，以解决高度未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818213152a6ed1e4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818213152a6ed1e4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2558366161","title":"Theriva Biologics, Inc.盘中异动 大幅上涨6.47%报0.395美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558366161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558366161?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:06","pubTimestamp":1754924788,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时06分，Theriva Biologics, Inc.股票出现异动，股价大幅上涨6.47%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5325.06%、449.65%、164.32%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新型溶瘤腺病毒平台，以解决高度未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811230629a48239e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811230629a48239e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2557578500","title":"Theriva Biologics, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557578500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557578500?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:56","pubTimestamp":1754661368,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时56分，Theriva Biologics, Inc.股票出现波动，股价快速下跌5.10%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新型溶瘤腺病毒平台，以解决高度未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808215608973bea7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808215608973bea7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2518828739","title":"Theriva Biologics, Inc.2024财年实现净利润-25.65百万美元，同比减少39.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518828739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518828739?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536085,"startTime":"0","endTime":"0","summary":"3月10日，Theriva Biologics, Inc.公布财报，公告显示公司2024财年净利润为-25.65百万美元，同比减少39.78%；其中营业收入为0.00美元，每股基本收益为-19.03美元。从资产负债表来看，Theriva Biologics, Inc.总负债20.67百万美元，其中短期债务600000.00美元，资产负债比为1.93，流动比率为2.15。机构评级：截至2025年3月10日，当前有1家机构对Theriva Biologics, Inc.目标价做出预测，其中目标均价为6.00美元，其中最低目标价为6.00美元，最高目标价为6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000311a268989e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000311a268989e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX"],"gpt_icon":0},{"id":"1165626744","title":"Theriva Biologics 2024财年GAAP每股收益$(19.03)，优于$(24.11)的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1165626744","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165626744?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:26","pubTimestamp":1741296399,"startTime":"0","endTime":"0","summary":"Theriva Biologics(TOVX) 2024财年GAAP每股收益$(19.03)，优于$(24.11)的预期。以上内容来自Benzinga Earnings专栏，原文如下：$Theriva Biologics(TOVX)$ FY 2024 GAAP EPS $(19.03) Beats $(24.11) Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Theriva Biologics 2024财年GAAP每股收益$(19.03)，优于$(24.11)的预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX"],"gpt_icon":0},{"id":"2516663458","title":"Theriva Biologics, Inc.盘中异动 临近收盘股价大跌5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516663458?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:42","pubTimestamp":1741034539,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时42分，Theriva Biologics, Inc.股票出现波动，股价快速跳水5.55%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044219abe699d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044219abe699d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2516946305","title":"Theriva Biologics, Inc.盘中异动 股价大涨7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516946305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516946305?lang=zh_cn&edition=full","pubTime":"2025-03-01 03:41","pubTimestamp":1740771693,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日03时41分，Theriva Biologics, Inc.股票出现异动，股价大幅上涨7.14%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Camp4 Therapeutics Corporation、Enveric Biosciences, Inc.、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3229.64%、587.33%、386.41%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、49.90%、48.19%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010341339896bc1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010341339896bc1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2514418190","title":"Theriva Biologics, Inc.盘中异动 股价大跌5.92%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514418190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514418190?lang=zh_cn&edition=full","pubTime":"2025-02-26 04:50","pubTimestamp":1740516650,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日04时50分，Theriva Biologics, Inc.股票出现异动，股价大幅跳水5.92%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为2125.92%、1184.71%、1025.50%，振幅较大的相关个股有Organovo Holdings, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为241.19%、224.55%、127.49%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226045050abdcd496&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226045050abdcd496&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2513214139","title":"Theriva Biologics, Inc.盘中异动 下午盘股价大跌5.28%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513214139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513214139?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:08","pubTimestamp":1740168505,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时08分，Theriva Biologics, Inc.股票出现波动，股价急速下跌5.28%。截至发稿，该股报1.53美元/股，成交量2.1091万股，换手率0.76%，振幅4.04%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222040825abd7f3f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222040825abd7f3f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2512485409","title":"Theriva Biologics, Inc.盘中异动 早盘大幅拉升5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512485409?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:59","pubTimestamp":1739977164,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时59分，Theriva Biologics, Inc.股票出现波动，股价大幅拉升5.73%。截至发稿，该股报1.66美元/股，成交量6020股，换手率0.22%，振幅5.73%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219225925988b366f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219225925988b366f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2512019639","title":"Theriva Biologics, Inc.盘中异动 下午盘大幅跳水6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512019639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512019639?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:00","pubTimestamp":1739905249,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时00分，Theriva Biologics, Inc.股票出现波动，股价急速下挫6.77%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Aditxt, Inc.、Allogene Therapeutics, Inc.、Solid Biosciences Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为810.83%、207.52%、166.94%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219030049a24ae48f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219030049a24ae48f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2511444529","title":"Theriva Biologics, Inc.盘中异动 股价大涨9.15%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511444529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511444529?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:58","pubTimestamp":1739458689,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时58分，Theriva Biologics, Inc.股票出现波动，股价大幅拉升9.15%。截至发稿，该股报1.67美元/股，成交量9327股，换手率0.34%，振幅1.28%。Theriva Biologics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Theriva Biologics, Inc.公司简介：Theriva Biologics Inc是一家临床阶段的制药公司，开发一种新的溶瘤腺病毒平台，以解决未满足需求的毁灭性癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213225809a244b1dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213225809a244b1dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TOVX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.therivabio.com","stockEarnings":[{"period":"1week","weight":0.0674},{"period":"1month","weight":-0.1155},{"period":"3month","weight":-0.3111},{"period":"6month","weight":-0.566},{"period":"1year","weight":-0.8662},{"period":"ytd","weight":-0.097}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Theriva Biologics, Inc.成立于1986年，是一家生物技术公司，专注于合成DNA为基础的疗法和治疗严重疾病的创新型疾病缓解药物的发展。该公司是一家多元化的临床阶段公司，开发旨在治疗高度未满足需求领域疾病的疗法。公司通过收购VCN Biosciences，SL进入肿瘤学领域，VCN Biosciences，SL开发了一种新的溶瘤腺病毒平台，设计用于静脉、玻璃体内和抗肿瘤递送以触发肿瘤细胞死亡，改善共同给药的癌症疗法对肿瘤的获取，并促进患者免疫系统产生强大而持续的抗肿瘤反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.186157},{"month":2,"riseRate":0.5,"avgChangeRate":0.027106},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.150503},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.004152},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.312515},{"month":6,"riseRate":0.333333,"avgChangeRate":0.107735},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.104421},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.095614},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.250272},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.113385},{"month":11,"riseRate":0.25,"avgChangeRate":0.035119},{"month":12,"riseRate":0.25,"avgChangeRate":-0.164416}],"exchange":"AMEX","name":"Theriva Biologics","nameEN":"Theriva Biologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Theriva Biologics(TOVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Theriva Biologics(TOVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Theriva Biologics,TOVX,Theriva Biologics股票,Theriva Biologics股票老虎,Theriva Biologics股票老虎国际,Theriva Biologics行情,Theriva Biologics股票行情,Theriva Biologics股价,Theriva Biologics股市,Theriva Biologics股票价格,Theriva Biologics股票交易,Theriva Biologics股票购买,Theriva Biologics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Theriva Biologics(TOVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Theriva Biologics(TOVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}